HITI - High Tide Inc.
NASDAQ
->
Healthcare
->
Pharmaceutical Retailers
Calgary,
Canada
Type: Equity
HITI price evolution
HITI
| (in millions $) | 31 Aug 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $2.64 | $4.1 | $4.48 | $7.57 |
| Inventory | $29.07 | $28.11 | $25.44 | $25.97 |
| Total current assets | $75.67 | $72.38 | $65.28 | $68.64 |
| Long term investments | ||||
| Property, plant & equipment | $63.14 | $61.73 | $60.48 | $57.78 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $238.46 | $234.46 | $227.31 | $233.4 |
| Current liabilities | ||||
| Accounts payable | $8.48 | $8.41 | $6.18 | $8.35 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $60.09 | $61.82 | $57.79 | $58.14 |
| Long term debt | $30.21 | $30.15 | $28.67 | $40.33 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $93.37 | $94.7 | $89.66 | $101.84 |
| Shareholders' equity | ||||
| Retained earnings | -$199.97 | -$198.98 | -$192.97 | -$193.19 |
| Other shareholder equity | $5.79 | $5.88 | $4.71 | $5.97 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 1 Dec 2021 | 30 Nov 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $14.01 | $5.6 | ||
| Short term investments | ||||
| Net receivables | $7.57 | $8.2 | $7.45 | $2.13 |
| Inventory | $25.97 | $23.41 | $17.04 | $4.24 |
| Total current assets | $68.64 | $64.06 | $46.29 | $14.34 |
| Long term investments | ||||
| Property, plant & equipment | $57.78 | $62 | $52.74 | $9.73 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $37.59 | |||
| Total investments | ||||
| Total assets | $233.4 | $274.74 | $246.22 | $51.93 |
| Current liabilities | ||||
| Accounts payable | $8.35 | $7.67 | $18.53 | $4.78 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $58.14 | $59.94 | $40.79 | $20.43 |
| Long term debt | $40.33 | $43.17 | $43.15 | $28.39 |
| Total noncurrent liabilities | $22.78 | |||
| Total debt | ||||
| Total liabilities | $101.84 | $118.39 | $99.01 | $43.21 |
| Shareholders' equity | ||||
| Retained earnings | -$193.19 | -$152.6 | -$77.07 | -$25.56 |
| Other shareholder equity | $5.97 | $6.38 | $0.21 | $6.57 |
| Total shareholder equity | ||||
| (in millions $) | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 | 1 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $131.69 | $124.26 | $128.07 | $127.11 |
| Cost of revenue | ||||
| Gross Profit | $35.45 | $35.3 | $35.99 | $32.98 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $30.97 | $32.19 | $32.05 | $31.82 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.67 | -$0.88 | -$0.23 | -$4.58 |
| Interest expense | -$2.98 | -$2.72 | -$2.68 | -$2.55 |
| Net income | ||||
| Net income | $0.72 | -$0.03 | -$0.34 | -$30.79 |
| Income (for common shares) | ||||
| (in millions $) | 1 Dec 2023 | 1 Dec 2022 | 1 Dec 2021 | 30 Nov 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $487.67 | $356.85 | $181.12 | $61.94 |
| Cost of revenue | ||||
| Gross Profit | $131.31 | $100.95 | $63.98 | $22.92 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $133.98 | $121.07 | $77.83 | $22.35 |
| Operating income | $0.59 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$7.64 | -$2.92 | -$0.73 | $0.17 |
| Interest expense | -$9.02 | -$0.25 | -$18.15 | $7.45 |
| Net income | ||||
| Net income | -$39.31 | -$71.76 | -$35.72 | -$4.73 |
| Income (for common shares) | ||||
| (in millions $) | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 | 1 Dec 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$7.61 | -$4.33 | -$2.08 | -$5.72 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$11.94 | -$10.13 | -$6.2 | -$9.26 |
| Effect of exchange rate | -$1.21 | -$0.8 | -$0.04 | -$0.65 |
| Change in cash and equivalents | $5.13 | $4.42 | -$1.44 | $5.04 |
| (in millions $) | 1 Dec 2023 | 1 Dec 2022 | 1 Dec 2021 | 30 Nov 2020 |
|---|---|---|---|---|
| Net income | -$4.73 | |||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $6.58 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$5.72 | -$8.59 | -$28.49 | -$2.46 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$9.26 | $15.17 | $37.81 | $0.87 |
| Effect of exchange rate | -$0.65 | |||
| Change in cash and equivalents | $5.04 | $11.07 | $6.49 | $5 |
News
Fundamentals
| Market cap | $145.61M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 80.45M |
| Revenue | $511.12M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$30.44M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -4.78 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.28 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.38 |
|---|---|
| ROA | -13.04% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.26 |
| Quick ratio | 0.78 |